Mirtazapine Tablets 30mg (Remeron® / レメロン錠30mg)

JPY ¥8,800

Japanese Noradrenergic and Specific Serotonergic Antidepressant (Mirtazapine 30mg). Oral tablet for depression and depressive states, administered once daily at bedtime. 100 tablets [10 tablets (PTP) x 10]. Mfd. by Organon Japan K.K., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥8,096
10 - 19 12% JPY ¥7,744
20 + 18% JPY ¥7,216
SKU: REM-30-TAB Category:

Description

Product Overview / 商品概要

Remeron Tablets 30mg (レメロン錠30mg)
Generic: Mirtazapine / ミルタザピン
Therapeutic Category: Noradrenergic and Specific Serotonergic Antidepressant (NaSSA) / ノルアドレナリン・セロトニン作動性抗うつ剤
Manufactured by: Organon Japan K.K. / オルガノン株式会社

Composition & Specification / 組成・規格

Active Ingredient: Mirtazapine 30mg per tablet / ミルタザピン 30mg(1錠中)
Additives: Corn starch, Hydroxypropylcellulose, Magnesium stearate, Light anhydrous silicic acid, Lactose hydrate, Hypromellose, Macrogol 6000, Titanium oxide, Yellow ferric oxide, Ferric oxide / トウモロコシデンプン、ヒドロキシプロピルセルロース、ステアリン酸マグネシウム、軽質無水ケイ酸、乳糖水和物、ヒプロメロース、マクロゴール6000、酸化チタン、黄色三二酸化鉄、三二酸化鉄
Appearance: Yellow-red film-coated tablet; dimensions approx. 7×13mm, thickness approx. 4.6mm, weight approx. 306mg; identification code: MSD TZ 5
外観: 黄赤色のフィルムコート錠、短径×長径:約7×13mm、厚さ:約4.6mm、重さ:約306mg、識別コード:MSD TZ 5

Indications / 効能効果

EN: Depression and depressive states
JA: うつ病・うつ状態

Dosage and Administration / 用法用量

EN: The usual initial dose for adults is 15mg of mirtazapine once daily at bedtime, with a maintenance dose of 15–30mg once daily. The dose may be adjusted based on age and symptoms, not to exceed 45mg per day. Dose increases should be made in increments of 15mg per day at intervals of at least one week.
JA: 通常、成人にはミルタザピンとして1日15mgを初期用量とし、15~30mgを1日1回就寝前に経口投与する。なお、年齢、症状に応じ1日45mgを超えない範囲で適宜増減するが、増量は1週間以上の間隔をあけて1日用量として15mgずつ行うこと。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to any component of this product. Patients currently receiving or within 2 weeks of discontinuing MAO inhibitors (selegiline hydrochloride, rasagiline mesilate, safinamide mesilate).
JA: 本剤の成分に対して過敏症の既往歴のある患者。MAO阻害剤(セレギリン塩酸塩、ラサギリンメシル酸塩、サフィナミドメシル酸塩)を投与中あるいは投与中止後2週間以内の患者。

Regulatory Information / 規制情報

Approval No.: 22800AMX00356000
Sales Started: May 2016 / 2016年5月
Classification Code: 871179
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 100 tablets [10 tablets (PTP) x 10] / 100錠[10錠(PTP)×10]
Other Available Packages (by special order): 100 tablets [10 tablets (PTP) x 10]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Mirtazapine Tablets 30mg (Remeron® / レメロン錠30mg)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Mirtazapine Tablets 30mg (Remeron®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.